Abstract
AbstractA series of sulfonamides containing 4‐aminoquinazoline scaffolds 7 a‐7 l was synthesized, characterized and evaluated for their in vitro antitubercular, antimicrobial and anticancer activity. The compounds with 4‐nitrophenyl (7 c), 3‐trifluoromethylphenyl (7 f) and 5‐chloro‐pyridin‐2‐yl (7 h) derivatives have shown potent antitubercular activity against Mycobacterium tuberculosis H37Rv strain and the activity was two‐fold higher than the standard drug Ciprofloxacin. The compounds with 4‐chlorophenyl (7 a), pyridin‐2‐yl (7 g), 5‐chloro‐pyridin‐2‐yl (7 h) and pyrimidin‐2‐yl (7 i, 7 j and 7 k) derivatives were observed as excellent antimicrobial agents. The preliminary toxicity of selected potent compounds was also tested on Red Blood Cells by hemolytic assay and found to be non‐toxic even at higher concentrations. Compounds with 4‐nitrophenyl (7 c) and 4‐fluorophenyl (7 e) substitutions emerged as potent molecules against MDA‐MB‐231 cell line. ADME (Absorption, Distribution, Metabolism and Excretion) screening study revealed that the compounds are strong candidates for antitubercular activity with good ADME parameters. In addition, the structure and antitubercular activity relationship were further supported by molecular docking studies of the active compounds against the DNA topoisomerase II (5BTC) enzyme of M. tuberculosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
